» Articles » PMID: 24142726

Fucoidan Induces G1 Phase Arrest and Apoptosis Through Caspases-dependent Pathway and ROS Induction in Human Breast Cancer MCF-7 Cells

Overview
Specialty General Medicine
Date 2013 Oct 22
PMID 24142726
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Fucoidan is an active component of seaweed, which inhibits proliferation and induces apoptosis of several tumor cells while the detailed mechanisms underlying this process are still not clear. In this study, the effect of Fucoidan on the proliferation and apoptosis of human breast cancer MCF-7 cells and the molecular mechanism of Fucoidan action were investigated. Viable cell number of MCF-7 cells was decreased by Fucoidan treatment in a dose-dependent manner as measured by MTT assay. Fucoidan treatment resulted in G1 phase arrest of MCF-7 cells as revealed by flow cytometry, which was associated with the decrease in the gene expression of cyclin D1 and CDK-4. Annexin V/PI staining results showed that the number of apoptotic cells was associated with regulation of cytochrome C, caspase-8, Bax and Bcl-2 at transcriptional and translational levels. Both morphologic observation and Hoechst 33258 assay results confirmed the pro-apoptotic effect of Fucoidan. Meanwhile, the ROS production was also increased by Fucoidan treatment, which suggested that Fucoidan induced oxidative damage in MCF-7 cells. The results of present study demonstrated that Fucoidan could induce G1 phase arrest and apoptosis in MCF-7 cells through regulating the cell cycle and apoptosis-related genes or proteins expression, and ROS generation is also involved in these processes.

Citing Articles

Fucoidan from Induces Apoptosis through Caspase Dependent and Caspase-Independent Activation in 4T1 Breast Adenocarcinoma In Vitro.

Cruz Riquelme R, Colona-Vallejos E, Alzamora-Gonzales L, Condori Macuri R Mar Drugs. 2024; 22(6).

PMID: 38921562 PMC: 11205089. DOI: 10.3390/md22060251.


Novel Fucoidan Pharmaceutical Formulations and Their Potential Application in Oncology-A Review.

Zahariev N, Katsarov P, Lukova P, Pilicheva B Polymers (Basel). 2023; 15(15).

PMID: 37571136 PMC: 10421178. DOI: 10.3390/polym15153242.


Polysaccharides from marine biological resources and their anticancer activity on breast cancer.

Yang S, Li D, Liu W, Chen X RSC Med Chem. 2023; 14(6):1049-1059.

PMID: 37360387 PMC: 10285744. DOI: 10.1039/d3md00035d.


Antiangiogenic drugs in combination with seaweed fucoidan: A mechanistic and study exploring the VEGF receptor and its downstream signaling molecules in hepatic cancer.

Abdollah M, Ali A, Elgohary H, Elmazar M Front Pharmacol. 2023; 14:1108992.

PMID: 36874031 PMC: 9982147. DOI: 10.3389/fphar.2023.1108992.


Immunopotentiating Activity of Fucoidans and Relevance to Cancer Immunotherapy.

Li Y, McGowan E, Chen S, Santos J, Yin H, Lin Y Mar Drugs. 2023; 21(2).

PMID: 36827169 PMC: 9961398. DOI: 10.3390/md21020128.


References
1.
Ye J, Li Y, Teruya K, Katakura Y, Ichikawa A, Eto H . Enzyme-digested Fucoidan Extracts Derived from Seaweed Mozuku of Cladosiphon novae-caledoniae kylin Inhibit Invasion and Angiogenesis of Tumor Cells. Cytotechnology. 2008; 47(1-3):117-26. PMC: 3449827. DOI: 10.1007/s10616-005-3761-8. View

2.
Hayashi K, Nakano T, Hashimoto M, Kanekiyo K, Hayashi T . Defensive effects of a fucoidan from brown alga Undaria pinnatifida against herpes simplex virus infection. Int Immunopharmacol. 2007; 8(1):109-16. DOI: 10.1016/j.intimp.2007.10.017. View

3.
Philchenkov A, Zavelevich M, Imbs T, Zvyagintseva T, Zaporozhets T . Sensitization of human malignant lymphoid cells to etoposide by fucoidan, a brown seaweed polysaccharide. Exp Oncol. 2007; 29(3):181-5. View

4.
Breckenridge D, Xue D . Regulation of mitochondrial membrane permeabilization by BCL-2 family proteins and caspases. Curr Opin Cell Biol. 2004; 16(6):647-52. DOI: 10.1016/j.ceb.2004.09.009. View

5.
Kang K, Kang B, Lee B, Che J, Li G, Trosko J . Preventive effect of epicatechin and ginsenoside Rb(2) on the inhibition of gap junctional intercellular communication by TPA and H(2)O(2). Cancer Lett. 2000; 152(1):97-106. DOI: 10.1016/s0304-3835(99)00438-3. View